Skip to content

BioConvergence pour la Santé

Domaine d’Intérêt Majeur (DIM) de la Région Île-de-France

DIM BioConvS’ Innovation Day

BioConvS at the Double•Science Festival

Call to action: scientific communication

Apply to the EIT Health SCI FI programme with BioConvS

Applications have been prolonged until June 30th 2023!

BioConvS at the Festival Double Science

Le DIM BioConvS est partenaire officiel du Festival Double Science, le festival de la médiation scie…

2023 PhD fellowships call

BioConvS’ first wave of PhD fellowships allocations is now closed. This call aims at funding p…

BioConvS at the Double•Science Festival

Apply to Genopole’s Shaker program

Do you have an innovating project to develop in a startup? Do you need help in developing your proof…

Logements pour chercheurs étrangers à la CIUP

Grands Lieux d’Innovation & SESAME Filière – webinar march 9

Medicen and the other innovation clusters of the Île-de-France Region are organizing an information …

SESAME Filière

Call for projects from the Ile-de-France Region for the structuring of strategic Ile-de-France secto…

Innovation competition: i-PhD

To meet the great challenge of doubling the number of Deeptech startups in France, the government in…

What is BioConvS?

BioConvergence for Health (BioConvS) is a Domain of Major Research and Innovation (DIM) funded by the Ile de France region. It aims to structure the communities of synthetic biology, biotherapy and bioproduction to guide the transition from scientific excellence to innovation, and to position Île-de-France region as an international reference in the domain. BioConvS, led by Université Paris Cité in partnership with Sorbonne and Paris-Saclay universities, Curie Institute (PSL), Micalis Institute (INRAe), Evry Genopole cluster, APHP and INSERM groups actors from the public and private sectors and benefits from 12.5M€ support from the Ile de France Region.

Principal axes

BioConvS gathers the Île-de-France scientific community working on the following axes:

  1. Life sciences engineering and bioproduction
  2. Development of therapeutics proofs-of-principles
  3. New, high throughput, standardisable analythic methods
  4. Digital or AI tools to improve data analysis or modelling in quality control and production methods
  5. Guarantee an inclusive, ethical, sustainable Bioconvergence

Distributed Biofoundry

BioConvS will support a network of distributed biofounderies (with the participation of Sorbonne University, INRAe, Institut Curie, Genopole and Université Paris Cité) to make technologies for life design and engineering accessible to Île-de-France Region public and private R&D. This will include the acquisition and pooling of high-tech equipment dedicated to the molecular engineering of living systems and bioproduction to create genetic circuits, synthetic cells and bioprocesses on demand.

CollectivE Digital Intelligence Platform (DICE)

BioConvS will develop an AI-supported framework of digital resources to design, document and share BioConvS researchers’ profiles, expertise and projects in a virtual collaborative research space. This platform, open to the general public, will strengthen the capacity for exchange between DIM’s partners and society.